Veterinary Assistive Reproduction Technology Market Size, Share & Trends Analysis Report By Animal Type (Bovine, Swine, Ovine, Caprine, Equine, Other Animals), By Product (Normal Semen, Sexed Semen), By Distribution Channel (Private, Public), By Conception Method (Artificial Insemination, Embryo Transfer (MOET), IVF), By Region, And By Segment Forecasts, 2025-2034.

Report Id: 2308 Pages: 179 Published: 19 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Veterinary Assistive Reproduction Technology Market Size is valued at USD 2.66 Bn in 2024 and is predicted to reach USD 5.48 Bn by the year 2034 at a 7.6% CAGR during the forecast period for 2025-2034.

Veterinary Assistive Reproduction Technology Market info

Veterinary assistive reproduction technology (ART) refers to any method of treatment or procedure that alters the reproductive cycle, gametes, or embryos in some way. There have been multiple iterations of this technology designed for usage with pets. The demand for assisted reproductive treatments and products is increasing due to the rising existence of infertility among the population base, which is caused by various illnesses such as sexually transmitted infections, post-partum infections, infections after abortions, and medically iatrogenic infections. Furthermore, leading research and development initiatives aimed at improving assisted reproductive technology and substantial industry participants consistently investing in creating new, improved products are expected to boost the market's growth.

However, the market development is hampered by the high-cost criteria for the safety and health of the veterinary assistive reproduction technology market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high veterinary assistive reproduction technology, the relatively high cost of ART products, in comparison to traditional treatments, a barrier to their adoption in both developed and underdeveloped nations. The fact that insurance does not cover or reimburse these procedures is another barrier preventing the assisted reproductive technology business from growing. However, the government may initiate initiatives to enhance ART technology and technical progress to circumvent this problem. The COVID-19 epidemic hit the assisted reproductive technology industry hard because patients were afraid to travel for treatments and because of inherent safety issues. With the COVID-19 epidemic, businesses took a nosedive for medical centres focusing on in vitro fertilization. To maintain reproductive health standards, some groups have started to take action.

Competitive Landscape

Some Major Key Players In The Veterinary Assistive Reproduction Technology Market:

  • Genus Plc
  • URUS Group LP
  • CRV
  • SEMEX
  • Select Sires, Inc.
  • Swine Genetics International
  • National Dairy Development Board
  • STgenetics
  • VikingGenetics
  • Geno SA
  • Others

Market Segmentation:

The veterinary assistive reproduction technology market is segmented based on animal type, product, distribution channel, and conception method. According to animal type, the market is segmented into bovine, swine, ovine, caprine, equine, and other animals. By product, the market is segmented into outlook normal semen and sexed semen. The distribution channel segment includes private and public. By conception method, the market is segmented into artificial insemination, IVF and embryo transfer (MOET).

Based On The Product Outlook, The Normal Semen Veterinary Assistive Reproduction Technology Market Segment Is Accounted As A Major Contributor To The Veterinary Assistive Reproduction Technology Market. 

The normal semen veterinary assistive reproduction technology market is expected to have a major global market share in 2022. Normal sperm is more affordable than sexed sperm, and the segment is very fertile. It captures a large portion of the market. Using frozen sperm, keeping bulls with high genetic value at sperm stations, and giving quality AI sperm doses all lead to better results.

Bovine Segment To Witness Growth At A Rapid Rate.

The bovine industry makes up the bulk of veterinary assistive reproduction technology usage for several reasons, including efforts by both public and private entities to promote sustainable food production, advancements in bovine reproduction technology, increased demand for dairy and beef products, and other similar aspects, especially in countries like the US, Germany, the UK, China, and India.

In The Region, The North American Veterinary Assistive Reproduction Technology Market Holds A Significant Revenue Share.

The North American veterinary assistive reproduction technology market is expected to record the maximum market revenue share in the near future. It can be attributed to because of the rising prevalence of infertility and the increasing popularity of fertility treatments. The combination of technological advancements and rising disposable income in North America is expected to boost demand for fertility treatments, which is good news for the regional market. In addition, Asia Pacific is projected to grow rapidly in the global veterinary assistive reproduction technology market because of the large number of animals, increasing public understanding of assisted reproductive technologies, and encouraging governmental programs.

Recent Developments:

  • In Feb 2022, A strategic collaboration between Zoetis, CowManager®, and Select Sires Inc. was officially initiated to integrate genomic tools and predictive sensor systems. The objective of this partnership was to generate value for cattle producers in the administration of their farms by providing enhanced guidance supported by intelligent, more precise cow data. Enhanced efficiency and well-informed decision-making by producers resulted in improved health outcomes for cows and favourable business performance.
  • In September 2020, Genus Plc ("Genus"), a frontrunner in animal genetic improvement, and Tropic, an innovator in agricultural biotechnology, announced an expansion and extension of their partnership to apply Tropic's GEiGS® technology to pig and cow genetics.

Veterinary Assistive Reproduction Technology Market Report Scope

Report Attribute Specifications
Market Size Value In 2024 USD 2.66 Bn
Revenue Forecast In 2034 USD 5.48 Bn
Growth Rate CAGR CAGR of 7.6% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Million and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Animal Type, By Product, By Distribution Channel, By Conception Method
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea
Competitive Landscape Genus Plc, URUS Group LP, CRV, SEMEX, Select Sires, Inc., Swine Genetics International, National Dairy Development Board, STgenetics, VikingGenetics, Geno SA, Others
Customization Scope Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Segmentation of Veterinary Assistive Reproduction Technology Market-

Veterinary Assistive Reproduction Technology Market By Animal Type-

  • Bovine
  • Swine
  • Ovine
  • Caprine
  • Equine
  • Other Animals

Veterinary Assistive Reproduction Technology Market Seg

Veterinary Assistive Reproduction Technology Market By Product-

  • Normal Semen
  • Sexed Semen

Veterinary Assistive Reproduction Technology Market By Distribution Channel-

  • Private
  • Public

Veterinary Assistive Reproduction Technology Market By Conception Method-

  • Artificial Insemination
  • Embryo Transfer (MOET)
  • IVF

Veterinary Assistive Reproduction Technology Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Veterinary Assistive Reproduction Technologies Market Snapshot

Chapter 4. Global Veterinary Assistive Reproduction Technologies Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Technology Advancement in Veterinary Assistive Reproduction Technologies Market

4.8. Key Trends in the Market

Chapter 5. Market Segmentation 1: Animal Type Estimates & Trend Analysis

5.1. Animal Type & Market Share, 2024 & 2034

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:

5.2.1. Bovine

5.2.2. Swine

5.2.3. Ovine

5.2.4. Caprine

5.2.5. Equine

5.2.6. Other Animals

Chapter 6. Market Segmentation 2: Product Estimates & Trend Analysis

6.1. Product & Market Share, 2024 & 2034

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:

6.2.1. Normal Semen

6.2.2. Sexed Semen

Chapter 7. Market Segmentation 3: Distribution Channel Estimates & Trend Analysis

7.1. Distribution Channel & Market Share, 2024 & 2034

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:

7.2.1. Private

7.2.2. Public

Chapter 8. Market Segmentation 4: Conception Method Estimates & Trend Analysis

8.1. Conception Method & Market Share, 2024 & 2034

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Conception Method:

8.2.1. Artificial Insemination

8.2.2. Embryo Transfer (MOET)

8.2.3. IVF

Chapter 9. Veterinary Assistive Reproduction Technologies Market Segmentation 6: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034

9.1.2. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034

9.1.3. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034

9.1.4. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034

9.1.5. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.1.5.1. U.S.

9.1.5.2. Canada

9.2. Europe

9.2.1. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034

9.2.2. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034

9.2.3. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034

9.2.4. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034

9.2.5. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) by country, 2021-2034

9.2.5.1. Germany

9.2.5.2. France

9.2.5.3. Italy

9.2.5.4. Spain

9.2.5.5. UK

9.2.5.6. Rest of Europe

9.3. Asia Pacific

9.3.1. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034

9.3.2. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034

9.3.3. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034

9.3.4. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034

9.3.5. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.3.5.1. China

9.3.5.2. India

9.3.5.3. Japan

9.3.5.4. Australia

9.3.5.5. Rest of Asia Pacific

9.4. Latin America

9.4.1. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, (US$ Million)

9.4.2. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034

9.4.3. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034

9.4.4. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034

9.4.5. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, (US$ Million) 2021-2034

9.4.5.1. Brazil

9.4.5.2. Rest of Latin America

9.5. MEA

9.5.1. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, (US$ Million) 2021-2034

9.5.2. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034

9.5.3. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034

9.5.4. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034

9.5.5. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, (US$ Million) 2021-2034

9.5.5.1. GCC Countries

9.5.5.2. South Africa

9.5.5.3. Rest of MEA

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Genus Plc

10.2.2. URUS Group LP

10.2.3. CRV

10.2.4. SEMEX

10.2.5. Select Sires, Inc.

10.2.6. Swine Genetics International

10.2.7. National Dairy Development Board

10.2.8. STgenetics

10.2.9. VikingGenetics

10.2.10. Geno SA

10.2.11. Other Prominent Player

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
7446
Security Code field cannot be blank!

Frequently Asked Questions

Veterinary Assistive Reproduction Technology Market Size is valued at USD 2.66 Bn in 2024 and is predicted to reach USD 5.48 Bn by the year 2034

Veterinary Assistive Reproduction Technology Market is expected to grow at a 7.6% CAGR during the forecast period for 2025-2034.

Select Sires, Inc., Swine Genetics International, National Dairy Development Board, STgenetics, VikingGenetics, Geno SA, Others

Veterinary assistive reproduction technology market is segmented based on animal type, product, distribution channel, and conception method.

North America region is leading the Veterinary assistive reproduction technology market.
Get Sample Report Enquiry Before Buying